NVIDIA, The Trade Desk, and Revolution Medicines Release Quarterly Earnings Reports

Key Facts

1NVIDIA Corporation released its Q4 2026 earnings call transcript.

2Revolution Medicines, Inc. released its Q4 2025 earnings call transcript.

3The Trade Desk, Inc. announced its financial results for Q4 2025.

Major US corporations across the technology, biotechnology, and advertising sectors have released their latest quarterly financial results, providing a comprehensive look at their fiscal performance. NVIDIA Corporation (NVDA) published its Q4 2026 earnings call transcript, a highly anticipated event given its role as a systemic driver for the semiconductor industry and the broader S&P 500. Simultaneously, The Trade Desk (TTD) announced its Q4 2025 results, offering insights into the current state of the digital advertising market. In the biotechnology sector, Revolution Medicines (RVMD) shared its Q4 2025 earnings details, highlighting progress in its clinical development pipeline. These reports come as investors closely monitor forward-looking guidance to gauge the health of high-growth sectors amid evolving macroeconomic conditions. The collective impact of these releases is expected to drive volatility in the QQQ and SPY ETFs, reflecting the significant market weight of these companies.